Prevention of β-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway

Journal of Neurochemistry

Volumn 75, Issue 3, 2000, Pages 1258-1263

  Favit, Antonella ^a   Grimaldi, Maurizio ^a   Alkon, Daniel L ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Amyloid; Alzheimer's disease; Neuron; Neurotoxicity; Proteasome; Protection

Indexed keywords

AMYLOID BETA PROTEIN; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ARTICLE; DEGENERATIVE DISEASE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ACETYLCYSTEINE; AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; FETUS; MULTIENZYME COMPLEXES; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINS;

EID: 0033845065     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0751258.x     Document Type: Article

References (22)

1. Ubiquitin, cellular inclusions and their role in neurodegeneration
2. The ubiquitin-proteasome proteolytic pathway
3. The ubiquitin-mediated proteolytic pathway: Mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins
4. Oxidative mechanisms in beta-amyloid cytotoxicity
5. Dephosphorylation targets bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway
6. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration
7. Alzheimer's-specific effects of soluble β-amyloid on PKCα and PKCγ degradation in human fibroblasts
8. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
9. Cannabidiol and (-)Delta-9-tetrahydrocannabinol are neuroprotective antioxidants
10. Substrate targeting in the ubiquitin system
11. Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative disease
12. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease
13. Molecular basis of the neurodegenerative disorders
14. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease
15. Neurite outgrowth in PC12 cells: Distinguish the roles of ubiquitinylation and ubiquitin-dependent proteolysis
16. 2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives to characterize specific binding sites
17. Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity
18. Amyloid β-protein induces necrotic cell death mediated by ICE cascade in PC12 cells
19. Hypoxia-ischemia induces a rapid elevation of ubiquitin conjugate levels and ubiquitin immunoreactivity in the immature rat brain
20. The cause of neuronal degeneration in Alzheimer's disease
21. Intracellular APP processing and A beta production in Alzheimer disease
22. β-Amyloid peptide fragment 31-35 induces apoptosis in cultured cortical neurons